Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma

Keith M. Skubitz, Philip A. Haddad

Research output: Contribution to journalArticlepeer-review

173 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences